This work is licensed under a Creative Commons Attribution 4.0 International License.
ACE2 (19-45)[T2A,I3L,A7L,N15M,A18L,F22L,S25L,S26A]
General Information
DRACP ID DRACP04378
Peptide Name ACE2 (19-45)[T2A,I3L,A7L,N15M,A18L,F22L,S25L,S26A]
Sequence SALEEQLKTFLDKFMHELEDLLYQLAL
Sequence Length 27
UniProt ID Q9BYF1
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antiviral
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C149H233N33O45S
Absent amino acids CGINPRVW
Common amino acids L
Mass 370271
Pl 4.1
Basic residues 3
Acidic residues 6
Hydrophobic residues 12
Net charge -3
Boman Index -2634
Hydrophobicity -1.11
Aliphatic Index 122.96
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 1490
Absorbance 280nm 57.31
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 33580154
Title Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection
Doi Not available
Year 2021
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 19258
This work is licensed under a Creative Commons Attribution 4.0 International License.